Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can't wait for California to figure out that they can't switch to electric vehicles if they already have rolling blackouts.
Mutants for Nuclear Power !
Electric Cars Matter !
...too soon ?
Da..it
Linde is one like Air Liquide
Speaking of volume...
This is simply interesting, could go up, could go down, blah blah blah...
But on the OBV (bottom) Notice how the Orange FIB is crossing above the Yellow FIB...
To me, that is very bullish
Meanwhile, the actual price action (top) is still pretty bearish
All I am saying is "interesting" and "I have no idea" just looking at this, what will happen next, ... at least, not for sure...
But OBV is the big rudder on the big ship; I think the alligator mouth opens upwards off of the orange line as it approaches the 9m mark, 3 - 5 days or so.
- chart from TradingView.com
I like it because I can do all kinds of customizations, although I only need a few, this is the only one that does the ones I like.
Is one of these in the list for this guy?
I get the best bang for the buck from the OBV with Fibs on it
That's interesting...
Whatever it is, we may not be the only ticker experiencing whatever it is
To my knowledge, we only shipped stacks.
That should be enough to go "Oh..."
Taiwan shows very good survival for cancers that are screened-for, i.e., caught at stage I
Seems the point of that report is "do more screening"
If you periodically scan the research papers, you'll notice that there have been recent advances in materials and temperature science, and that changes things that are not already sold pending delivery.
The SOFC here has been a DoD baby for many years already.
If they are talking about better seals now, then it is easy to imagine nearing commercialization.
Shoot from the hip, call it 3 years more, in keeping with the 3 year plan.
I think it is unlikely because Geert is on record saying what he has said.
It would be walking an incredibly fine line to be on the record the way they are and also "stalling for time" so to speak.
I think it is more likely that we should take this all at face value "Let's do this right the first time"
If you do that, I would expect a sell-off profit taking upon good news, i.e., it will shoot high, then fall back. That is a buy point because then it will shoot up higher.
I think what you mean to say is something more like "If we just missed 10%, what about the secondary end-point, 'quality of life'"
And technically that can be a winner in its own right
Like you were saying earlier though, it feels like we are teetering around 10% for everything we just talked about.
Also I don't think they would halt it if we made 8%+. Sure it is not the design goal but it is still, today, significant. At the time this started FDA was way more strict. 8% is still science...
I just can't come up with a way to do that even with dropouts
Something would be on "tilt", hard to believe
Back of the napkin
Say 2 remaining events are needed
There are some 9 year people and some 4 year people
If 2 9 year events happen that is a difference of 2 events at 5 years ++
If 2 4 year events happen that may be par for the SOC course
Then, which group(s) did the events happen in ? Do they wash ?
This starts to take shape when you consider that there COULD be a differential of 30 between test and control. Then you can see that how much longer or not one or two events lived is very significant (can be).
The two events could make a movement of some months in gross. Some months is enough to move the needle from red to green or vice versa.
Conclusion must be ( and I have been very concerned with the issue ) ... must be that there was no way to solidly "what-if" the remaining events.
And yes, that suggests (to me, also?) this is closer that we might wish.
To that you can add that there is great difficulty accounting for the trial duration with simply adding drop-outs, etc., to the point where there is significant pressure for the reason why to be that the SOC group performed better than the 200,000+ events SEER database suggests.
With all that, I'm still at 11.25% OS benefit to the test group, and that is not easy to do, but it is also not easy to discount any further.
Yeah, the anti-inflammatory seems to be very important.
If you think about it, a tumor establishes its own blood vessel network, meanwhile the swelling cuts off other avenues. So reducing swelling should help get the lymphatics in-gear for everybody making an effort.
CIZ has anti-inflammatory agent, i.e., we do that too...
Here is one update from a long time ago (we were discussing BNCT and we kinda better hurry up)
https://www.iaea.org/newscenter/news/a-major-step-forward-in-establishing-boron-neutron-capture-therapy-as-a-routine-cancer-therapy-option
It's a PII-sized study
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32950
Watching the webcast right now, not sure if it is a repeat or a do-over, says starts at 1:30 eastern
It is still a good idea to burn and fixate CD-ROM
Every time we have something that is potentially secure(able), it is deprecated
Yeah, go figure... somebody noticed and then some trials started
https://www.medpagetoday.com/infectiousdisease/covid19/88119
Seems like a lot of "aha" moments are coming up for COVID 19
https://www.medpagetoday.com/infectiousdisease/covid19/88560
That topic addresses a few observations from the past, ACE2, Hemorrhagic, "high altitude sickness"...
Did y'all see the one about Pepcid AC ?
The point is that there has to BE nat gas to put in the things
If you have no pipeline, then you have rail, higher cost (and environmental risk)
It is simply very real
I look to more California before East Coast
...And again, consider "up-stream" issues while you're at it...
https://www.greentechmedia.com/articles/read/dominion-to-sell-natural-gas-business-and-cancel-atlantic-coast-pipeline#:~:text=Dominion's%20renewable%20plans%20part%20of,economic%20viability%20of%20the%20project.%E2%80%9D
If you go back in time, yes there was a stack lifetime issue
This was remedied, mostly, about the time they bought a $50m oven
Check again, I think that was from 2019
Imagine you could fast forward about a decade or so...
Will you still be talking like this considering we could still well be in exactly the same position ?
Point being... amazing patience is necessary here.
The reward is amazing pops.
Simply any news of new sales will do it, just one
It looked good and exactly as expected to me...
"good" being a relative term
Probably the thing to note is the imminent doubling of generation / recurring revenue as projects complete.
Also, I for one, like it when they take care of a customer and replace a stack. This demonstrates customer care, as well as continued improvement.
The telegraphing is "3 year transformative plan"
Kinda feels like they are saving a bunch of "good stuff" for an upcoming quarter.
Maybe we should pool our resources and buy one of these...
A new sale would do wonders for the share price
Exactly
That was the "open label study" part, everybody knows everything, where "everybody" means Doctors and Patients.
A "placebo" injection(s) would serve no purpose other than to possibly complicate someone's health-care options in a life threatening situation.
I've seen to it that they are aware of each other, so we'll see...
Here it is then
LEAPS was funded by who ?
It is a flexible platform with select-able anti-viral payload
Like loading a different warhead into a missile
What is missing ?
RADAR
Now then...
This is one that could go well with LEAPS, as mentioned earlier.
It goes by (FLURF)
Not sure what to expect from here... I think it has legs over weeks.
I suppose it will ping off of about .50 and collapse a bit maybe back to .20's, and that for me is "buy more".
It could blow through .50 and keep going though...
So far there is not insignificant profit taking or bailing when the bailing is good for those disillusioned so far.
This is a new game for this one.
So far so good...
I love it when I look like a genius, hope it lasts into the close
Yeah I got 3k a while ago, probably around .16
The only reason why is because 2 days before they announced an effort in this direction I emailed 'em "Hey, isn't this tech applicable for covid testing with the right reagents?" ... they couldn't respond because it was already in the works.
Otherwise it is a dog because nobody has $30k to drop on those things for their crops that there are existing testing facilities for, over time it is more expensive to do what they are doing without this thing. They just can't land the sales for that purpose.
Maybe we should restart the conversation
Simply, the SOC group does not get multikine, this is the "control group".
We were talking earlier about "placebo", this is a technique used to establish control groups. It is not applicable here. The protocol for enrollment into test and control (and auxiliary) groups does that function.
I imagine that the delay between diagnosis and starting SOC treatment is about the same. I don't know that, but I imagine that. You have to schedule surgery and usually it is not next day available.
It would make some sense if there is some protocol control over when surgery starts, but it would also make sense to ignore it, and "everybody proceeds with SOC" and we are opportunistic to introduce MK prior to the surgery.
This also, you would think, washes out, because not everybody will get a diagnosis at exactly the same moment in their cancer progression.
fyi - watching FLURF
While we're waiting here, I've been watching odd-ball things like FLURF.
Originally it is spectroscopy for crop analysis, management, and detection of contaminants. It has been hard for them to make sales.
Meanwhile, they apparently successfully adapted the tech for mass testing for Covid using saliva. Dunno if y'all have had the pleasure of a "brain poke" swabbing... by comparison.
The initial testing claims it can run 3,000 tests per hour.
There is news on that today at least for shareholders, proof of concept worked.
Point being, cheap speculative play.